Correction: Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies

Gangling Xu, Jing Jin, Zhihao Fu, Guangming Wang, Xinhua Lei, Jun Xu, Junzhi Wang · 2026

Read Correction: Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies by Gangling Xu, Jing Jin, Zhihao Fu, Guangming Wang, Xinhua Lei, Jun Xu, Junzhi Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13594204.txt.

Description

Gangling Xu and co-authors published a correction to their review of extracellular vesicle-based drugs, fixing three descriptive errors about particle sizes that crept in during drafting. The review itself had appeared in Signal Transduction and Targeted Therapy in 2025, surveying how these tiny membrane parcels might carry medicines, and how their quality and safety should be checked.

The corrected text now states that microvesicles span roughly fifty to one thousand nanometers. These bud directly from the cell surface. Exosomes, released after forming inside the cell, span roughly forty to one hundred sixty. A table entry giving the overall size spread was likewise adjusted to forty to one thousand nanometers, noting the overlap between the two types. The authors stress that the slips were clerical and that every conclusion of the review stands unchanged.

Catalog record

CREATORGangling Xu, Jing Jin, Zhihao Fu, Guangming Wang, Xinhua Lei, Jun Xu, Junzhi Wang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13594204

Browse the full library · About the Tower of Babel